STARTING FROM MEDICAL REPRESENTATIVE TO MAKING INDIA'S BIGGEST COMPANY.

STARTING FROM MEDICAL REPRESENTATIVE TO MAKING  INDIA'S BIGGEST COMPANY - R C JUNEJA'S SUCCESS STORY OF MANKIND PHARMA:

Mankind Pharma, which started off with an investment of Rs 50 lakh, has become the sixth largest pharma company with revenue of 60 crores USD between 2014 -15 .

After completing his graduation in science, he started his career in 1974 with Kee Pharma, working as a medical representative. In 1975, he joined Lupin & worked there as first line manager for almost 8 years. In 1983 he resigned from lupin limited & started his own company Bestochem in Partnership. In 1994, he withdrew his ownership from Bestochem and in 1995 incepted Mankind Pharma along with his younger brother Mr. Rajeev Juneja with an investment of Rs. 50 lakhs and an initial team of 25 Medical Representatives.

Under the supervision of R C Juneja, Mankind thrived from a Rs. 3.49 crores company in 1995 to a company having revenue 60 crores USD  in revenues by 2014-15.

Mankind Pharma was started with an investment of merely Rs 50 lakh and only 20 employees. Today, we are among the top five fastest growing pharmaceutical companies of India with an employee base of more than 10,000 and heading towards a turnover of 60 crores USD.

Mankind  aspires to aid the community in leading a healthy life through two  parallel objectives: formulating, developing &  commercializing medicines and delivering affordable & accessible medication that satisfies urgent medical needs.

Mankind’s strong portfolio of businesses, geographies and products ranging from pharma to popular OTC & FMCG brands — Unwanted72,  Prega News, Kustody, Adiction, Gas-O-Fast, and Manforce condoms provide mankind the strategic benefits of integration that allow them to perform best in an increasingly competitive market.

In 2010, Mankind launched its first overseas market, SriLanka and we are expanding the horizon in Vietnam, Philippines, Myanmar, African market, CIS and other regulated and semi-regulated markets by 2015.

·       How the company differentiating itself from other pharma players?

The  Mankind Pharma’s mission is to provide high quality medicines at affordable prices for healthier lives, with the business model spanning across three segments: generics, active pharmaceutical ingredients and OTC products.

The company analysed that Indian companies' increase or hike their prices when the cost of active pharmaceutical ingredient (API) imported from other countries goes up. However, when API’s price falls, the prices of the medicines are not regulated or reduced.

For example: This is the main reason why Mankind Pharma has been able to sell at a less than half its rivals cost, its antibiotic Moxikind CV was launched and selling for Rs 13 against competitors’ brands priced at approx. Rs 40.

With a ‘Bottom to top of the pyramid’ approach, Mankind Pharma has been able to penetrate with affordable and easily available drugs in rural  India’s small towns and villages, which had been neglected otherwise.

According to IMS Health, a US-based firm that collects proprietary industry data, Mankind Pharma was present in every village in India that had 1,000 or more inhabitants in 2009, which contributed to 58% of the company’s revenue.

Mankind is  having the largest sales force in the sector for penetrating nook and corner of the country and manage a very low attrition rate at half the industry level.